Enhanced Telehealth in Prostate Cancer

Is a telehealth program enhanced by key at-home medical services (enhanced telehealth) feasible for the care of patients with prostate cancer receiving androgen deprivation therapy?This quality improvement study with 38 participants found that enhanced telehealth was feasible, with greater than 60% completion across all scheduled visits and strong endorsement of benefit from both patients and clinicians.These results support further development and evaluation of enhanced telehealth as a care delivery strategy for patients with prostate cancer.

Corresponding Author: Erin M. Bange, MD, MSCE, Department of Medicine, Memorial Sloan Kettering Cancer Center, 353 E 68th St, New York, NY 10065 (bangee@mskcc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.